161 related articles for article (PubMed ID: 21788040)
1. Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Pro.
Herr HW
J Urol; 2011 Sep; 186(3):787-8. PubMed ID: 21788040
[No Abstract] [Full Text] [Related]
2. [Transurethral surgical treatment of invasive bladder tumors (T1 and T2)].
Wolf H; Iversen HG; Olsen PR; Højgaard K; Schroeder T
Ugeskr Laeger; 1987 Nov; 149(48):3247-50. PubMed ID: 3433525
[No Abstract] [Full Text] [Related]
3. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
4. The value of a second transurethral resection in evaluating patients with bladder tumors.
Herr HW
J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
[TBL] [Abstract][Full Text] [Related]
5. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.
Sivalingam S; Probert JL; Schwaibold H
BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194
[No Abstract] [Full Text] [Related]
6. A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors.
Aydin M; Tandogdu Z; Kurtulus FO; Avci E; Fazlioglu A; Cek M
J BUON; 2010; 15(3):514-7. PubMed ID: 20941820
[TBL] [Abstract][Full Text] [Related]
7. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
[TBL] [Abstract][Full Text] [Related]
8. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
Stein JP; Penson DF
BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
[TBL] [Abstract][Full Text] [Related]
9. [Endosurgery in treatment of urinary bladder cancer in elderly patients].
Alferov SM; Grishin MA; Emel'ianenko AV
Khirurgiia (Mosk); 2010; (9):30-5. PubMed ID: 21164419
[TBL] [Abstract][Full Text] [Related]
10. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
Richards KA; Smith ND; Steinberg GD
J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
[TBL] [Abstract][Full Text] [Related]
11. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2004. A 57-year-old man with invasive transitional-cell carcinoma of the bladder.
Kaufman DS; Shipley WU; McDougal WS; Young RH
N Engl J Med; 2004 Jan; 350(4):394-402. PubMed ID: 14736932
[No Abstract] [Full Text] [Related]
12. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
14. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial.
Divrik RT; Sahin AF; Yildirim U; Altok M; Zorlu F
Eur Urol; 2010 Aug; 58(2):185-90. PubMed ID: 20303646
[TBL] [Abstract][Full Text] [Related]
15. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
[TBL] [Abstract][Full Text] [Related]
16. [Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?].
Rouprêt M; Guillotreau J; Irani J; Zerbib M
Prog Urol; 2010 Mar; 20 Suppl 1():S46-9. PubMed ID: 20493444
[TBL] [Abstract][Full Text] [Related]
17. Transurethral resection specimens of the bladder: outcome of invasive urothelial cancer involving muscle bundles indeterminate between muscularis mucosae and muscularis propria.
Miyamoto H; Epstein JI
Urology; 2010 Sep; 76(3):600-2. PubMed ID: 20394971
[TBL] [Abstract][Full Text] [Related]
18. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
19. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
[TBL] [Abstract][Full Text] [Related]
20. High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor.
Herr HW
Semin Urol Oncol; 1997 Aug; 15(3):142-6. PubMed ID: 9394908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
